Category: Cardiometabolic & Disease Risk
-
The 2026 Dyslipidemia Guidelines and the Rise of the Lifetime Exposure Model
It stops treating cholesterol as a number to manage in midlife and reframes it as a lifelong exposure to manage from childhood.
-
Heart Rate Variability: The Rhythm Between Heartbeats
Far from being physiological noise, these beat-to-beat variations convey rich information about an individual’s adaptive capacity, resilience to stress, and overall health status.
-
The Sardine Tin Every Woman on Statins Deserves
Women on statins may be the canaries in the metabolic coal mine, manifesting adverse effects earlier and more severely than men.
-
The Hidden Metabolic Cost of a Cardio-Protective Cornerstone
To what extent are we exchanging one domain of risk, atherosclerotic cardiovascular disease, for another progressive metabolic dysfunction?
-
When Prestige Wellness Meets the Algorithm
True luxury resides in an extended, vibrant health span forged through personalized, evidence-grounded daily practices rather than ephemeral premium indulgences.
-
When Salt Takes the Fall for Insulin
Elevated blood pressure reflects not a primary excess of sodium per se, but a downstream expression of insulin resistance and maladaptive renal sodium handling.
-
Apolipoprotein C‑III as a Metabolic Brake on Triglyceride Remnants Cardiovascular Risk and Human Longevity
ApoC3 slows triglyceride‑rich lipoprotein clearance, amplifying remnant cholesterol exposure and vascular inflammation, while lifelong ApoC3 lowering links to fewer coronary events and longer survival.
-
The Triglyceride-to-HDL Cholesterol Ratio as a Pragmatic Index of Atherogenic Dyslipidemia, Insulin Resistance, and Cardiometabolic Longevity Risk
The triglyceride-to-HDL cholesterol ratio condenses insulin resistance, atherogenic dyslipidemia, and vascular aging risk into a single, low-cost, routinely available biomarker with broad clinical utility.